Corteva (NYSE:CTVA) Price Target Raised to $90.00

Corteva (NYSE:CTVA) had its price objective hoisted by Deutsche Bank Aktiengesellschaft from $85.00 to $90.00 in a research note published on Thursday morning,MarketScreener reports. The brokerage currently has a buy rating on the stock.

Other research analysts have also recently issued reports about the company. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and lifted their price target for the company from $75.00 to $77.00 in a research report on Thursday. Wolfe Research lifted their target price on shares of Corteva from $80.00 to $81.00 and gave the company an “outperform” rating in a report on Friday, January 16th. The Goldman Sachs Group reissued a “buy” rating and set a $88.00 price target on shares of Corteva in a report on Thursday. Zacks Research upgraded shares of Corteva from a “hold” rating to a “strong-buy” rating in a research report on Thursday, January 22nd. Finally, Mizuho upped their price objective on shares of Corteva from $78.00 to $80.00 and gave the stock an “outperform” rating in a research report on Friday, January 16th. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.37.

Corteva Trading Up 0.2%

Shares of Corteva stock opened at $72.63 on Thursday. The stock has a market cap of $49.08 billion, a PE ratio of 45.97, a price-to-earnings-growth ratio of 1.84 and a beta of 0.75. The firm has a fifty day moving average price of $68.82 and a 200 day moving average price of $68.39. Corteva has a 1 year low of $53.40 and a 1 year high of $77.41. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 1.07.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period last year, the firm earned $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts predict that Corteva will post 2.96 earnings per share for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. The ex-dividend date of this dividend is Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a dividend yield of 1.0%. Corteva’s dividend payout ratio is presently 45.57%.

Institutional Trading of Corteva

A number of institutional investors have recently made changes to their positions in the company. Evoke Wealth LLC boosted its stake in Corteva by 6.1% during the 4th quarter. Evoke Wealth LLC now owns 6,473 shares of the company’s stock worth $434,000 after purchasing an additional 371 shares during the last quarter. Axxcess Wealth Management LLC lifted its stake in shares of Corteva by 68.5% in the fourth quarter. Axxcess Wealth Management LLC now owns 51,840 shares of the company’s stock worth $3,475,000 after buying an additional 21,075 shares in the last quarter. Global Retirement Partners LLC lifted its stake in shares of Corteva by 25.4% in the fourth quarter. Global Retirement Partners LLC now owns 6,997 shares of the company’s stock worth $469,000 after buying an additional 1,418 shares in the last quarter. Twin Capital Management Inc. boosted its position in Corteva by 178.9% during the fourth quarter. Twin Capital Management Inc. now owns 25,394 shares of the company’s stock worth $1,702,000 after acquiring an additional 16,288 shares during the last quarter. Finally, Leonteq Securities AG purchased a new stake in Corteva during the 4th quarter valued at about $2,350,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Several sell‑side firms lifted targets and kept bullish ratings, signaling analyst confidence in longer‑term upside: Deutsche Bank to $90 (buy), Wolfe Research to $86 (outperform), and RBC to $89 (outperform). Deutsche Bank raise Wolfe Research raise RBC raise
• Positive Sentiment: Brokerage consensus remains constructive (consensus “Moderate Buy”), which supports demand for the shares despite near‑term noise. Consensus Moderate Buy
• Positive Sentiment: Strategic commentary highlights Corteva’s expanding role in global agriculture and technology leadership—positive for medium‑term growth expectations. Corteva expands role
• Neutral Sentiment: Analyst views are mixed across publications — some highlight long‑term upside tied to licensing and settlements, while others argue valuation limits near‑term gains. Investors should weigh catalyst timing. Bull case analysis Conflicting analyst views
• Neutral Sentiment: Technical analysis pieces warn of a key structural test — useful for traders but not definitive for fundamentals; could increase short‑term volatility. Technical caution
• Negative Sentiment: Q4 results missed revenue expectations (seasonal timing and weaker crop‑protection/seed demand); revenue miss and a wider loss drove an after‑hours selloff. Those operational misses are the main near‑term headwind. Q4 revenue miss After‑hours fall
• Negative Sentiment: JPMorgan downgraded Corteva from overweight to neutral (citing valuation/limited near‑term upside), which can cool momentum among institutional buyers. JPMorgan downgrade
• Negative Sentiment: Market reaction to the earnings miss (seasonal timing) and mixed guidance elements increases short‑term uncertainty even as analysts argue for longer‑term upside — expect higher intraday volatility. Seasonal timing impact

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.